Inovio Pharmaceuticals (INO) stock forecast for 2025. Forecast tables and graphs.

Inovio Pharmaceuticals (INO) stock forecast for 2025

The forecast has been updated: October 14, 2021 4:44


Inovio Pharmaceuticals stock price online today

Analyst Target Price

13.22

Dividend Date

-

Ex Dividend Date

-

Last Split Factor

1:4

Last Split Date

06.06.2014

Should you buy or sell Inovio Pharmaceuticals stock stock today? What is the projected target price level for 2025? How much will it cost in 2025? Inovio Pharmaceuticals stock Stock Monthly Prediction for January, February, March, April, May, July, July, August, September, October, November and December 2025.

We predict the dynamics of the stock market value using resonant artificial intelligence systems.

Technical, fundamental analyzes, news background, general geopolitical situation in the world and other factors are taken into account.

Forecasts are adjusted once a day taking into account the price change of the previous day.

To date, analysts have a $13.22 target price for Inovio Pharmaceuticals stock stock.

Today 200 Day Moving Average is the resistance level (8.11 $).

50 Day Moving Average is the resistance level (7.75 $).




INO Forecast for 2025

Month Rate Forecast MIN Rate MAX Rate Volati-
lity, %
Jan 9.39 8.96 9.65 7.20 %
Feb 9.53 9.12 9.83 7.27 %
Mar 8.86 8.25 9.48 12.99 %
Apr 8.51 8.29 9.03 8.29 %
May 8.38 8.11 8.69 6.65 %
Jun 8.15 7.68 8.54 10.11 %
Jul 8.26 8.05 8.50 5.25 %
Aug 8.76 8.20 8.93 8.14 %
Sep 9.53 8.95 10.29 12.96 %
Oct 10.43 9.63 10.81 10.91 %
Nov 10.09 9.79 10.65 8.05 %
Dec 10.87 10.37 11.17 7.11 %

The forecasts table above shows the forecast values of the company's stock price for each month. The Rate Forecast column displays the Optimal Average Forecast Price. The MIN Rate column displays a pessimistic forecast for this month. “MAX Rate” is an optimistic forecast. The % Volatility column represents the approximate monthly volatility of Inovio Pharmaceuticals stock.


Inovio Pharmaceuticals overview

Inovio Pharmaceuticals Address

6769 MESA RIDGE RD., SAN DIEGO, CA, US

Market Capitalization

1 478 810 000 $

EBITDA

-108 041 976

PE Ratio

None

PEG Ratio

0

Dividend Per Share

None

Dividend Yield

0

EPS

-0.754

Quarterly Earnings Growth YOY

0

Quarterly Revenue Growth YOY

0.021

Trailing PE

0

Forward PE

0

EV To Revenue

157.96

EV To EBITDA

0

52 Week High

19

52 Week Low

5.81

50 Day Moving Average

7.75

200 Day Moving Average

8.11

Shares Outstanding

210357000

Shares Float

206968000

Shares Short Prior Month

44453900

Short Ratio

12.06

Percent Insiders

1.656

Percent Institutions

35.96

Inovio Pharmaceuticals stock forecast for this year


Inovio Pharmaceuticals stock forecast for Jan 2025.
Estimated Average Forecasted Inovio Pharmaceuticals Price: 9.39. Negative monthly dynamics of the instrument is expected with 7.198% volatility is expected.

Pessimistic forecast: 8.96

Optimistic: 9.65


Inovio Pharmaceuticals stock forecast for Feb 2025.
Estimated Average Forecasted Inovio Pharmaceuticals Price: 9.53. Positive monthly dynamics of the instrument is expected with 7.267% volatility is expected.

Pessimistic forecast: 9.12

Optimistic: 9.83


Inovio Pharmaceuticals stock forecast for Mar 2025.
Estimated Average Forecasted Inovio Pharmaceuticals Price: 8.86. Negative monthly dynamics of the instrument is expected with 12.991% volatility is expected.

Pessimistic forecast: 8.25

Optimistic: 9.48


Inovio Pharmaceuticals stock forecast for Apr 2025.
Estimated Average Forecasted Inovio Pharmaceuticals Price: 8.51. Negative monthly dynamics of the instrument is expected with 8.286% volatility is expected.

Pessimistic forecast: 8.29

Optimistic: 9.03


Inovio Pharmaceuticals stock forecast for May 2025.
Estimated Average Forecasted Inovio Pharmaceuticals Price: 8.38. Negative monthly dynamics of the instrument is expected with 6.654% volatility is expected.

Pessimistic forecast: 8.11

Optimistic: 8.69


Inovio Pharmaceuticals stock forecast for Jun 2025.
Estimated Average Forecasted Inovio Pharmaceuticals Price: 8.15. Negative monthly dynamics of the instrument is expected with 10.115% volatility is expected.

Pessimistic forecast: 7.68

Optimistic: 8.54


Inovio Pharmaceuticals stock forecast for Jul 2025.
Estimated Average Forecasted Inovio Pharmaceuticals Price: 8.26. Positive monthly dynamics of the instrument is expected with 5.248% volatility is expected.

Pessimistic forecast: 8.05

Optimistic: 8.50


Inovio Pharmaceuticals stock forecast for Aug 2025.
Estimated Average Forecasted Inovio Pharmaceuticals Price: 8.76. Positive monthly dynamics of the instrument is expected with 8.137% volatility is expected.

Pessimistic forecast: 8.20

Optimistic: 8.93


Inovio Pharmaceuticals stock forecast for Sep 2025.
Estimated Average Forecasted Inovio Pharmaceuticals Price: 9.53. Positive monthly dynamics of the instrument is expected with 12.963% volatility is expected.

Pessimistic forecast: 8.95

Optimistic: 10.29


Inovio Pharmaceuticals stock forecast for Oct 2025.
Estimated Average Forecasted Inovio Pharmaceuticals Price: 10.43. Positive monthly dynamics of the instrument is expected with 10.907% volatility is expected.

Pessimistic forecast: 9.63

Optimistic: 10.81


Inovio Pharmaceuticals stock forecast for Nov 2025.
Estimated Average Forecasted Inovio Pharmaceuticals Price: 10.09. Negative monthly dynamics of the instrument is expected with 8.049% volatility is expected.

Pessimistic forecast: 9.79

Optimistic: 10.65


Inovio Pharmaceuticals stock forecast for Dec 2025.
Estimated Average Forecasted Inovio Pharmaceuticals Price: 10.87. Positive monthly dynamics of the instrument is expected with 7.109% volatility is expected.

Pessimistic forecast: 10.37

Optimistic: 11.17



Other Healthcare sector assets

Name Symbol Last Close Price Change
Abbott Laboratories
ABT 117.49 (15.10.2021) -0.07 %
AbbVie Inc.
ABBV 109.33 (15.10.2021) 0.39 %
Aeterna Zentaris Inc.
AEZS 0.6043 (15.10.2021) -2.58 %
Allakos Inc.
ALLK 107.48 (15.10.2021) 0.34 %
Allogene Therapeutics, Inc.
ALLO 16.48 (15.10.2021) -4.02 %
Amgen Inc.
AMGN 207.84 (15.10.2021) 0.51 %
Aphria Inc.
APHA 15.38 (07.05.2021) 0.00 %
Atara Biotherapeutics, Inc.
ATRA 15.12 (15.10.2021) -4.06 %
Aurora Cannabis Inc.
ACB 7.03 (15.10.2021) -3.17 %
Becton Dickinson and Company
BDX 241.16 (15.10.2021) -0.63 %
Biogen Inc.
BIIB 281.19 (15.10.2021) -1.43 %
Biohaven Pharmaceutical Holding Company Ltd.
BHVN 133.61 (15.10.2021) -0.88 %
BioNTech SE
BNTX 247.68 (15.10.2021) -1.06 %
bluebird bio, Inc.
BLUE 20.9 (15.10.2021) 1.41 %
Boston Scientific Corp.
BSX 43.4 (15.10.2021) 0.35 %
Bristol-Myers Squibb Company
BMY 58.36 (15.10.2021) 1.14 %
Canopy Growth Corp.
CGC 13.35 (15.10.2021) -2.55 %
Castle Biosciences, Inc.
CSTL 63.58 (15.10.2021) -2.33 %
CLOVER HEALTH INVESTMENTS, CORP
CLOV 7.91 (15.10.2021) -2.59 %
Eli Lilly and Company
LLY 237.88 (15.10.2021) 0.50 %
Emergent BioSolutions Inc.
EBS 50.69 (15.10.2021) -1.48 %
Exelixis, Inc.
EXEL 21.82 (15.10.2021) -0.09 %
G1 Therapeutics, Inc.
GTHX 12.77 (15.10.2021) 0.95 %
Gilead Sciences, Inc.
GILD 67.63 (15.10.2021) -0.76 %
GlaxoSmithKline plc
GSK 39.01 (15.10.2021) 0.75 %
GoodRx Holdings, Inc.
GDRX 42.42 (15.10.2021) -1.35 %
GW Pharmaceuticals plc.
GWPH 218.96 (05.05.2021) 0.00 %
Incyte Corp.
INCY 65.56 (15.10.2021) -0.33 %
Inovio Pharmaceuticals, Inc.
INO 7.02 (15.10.2021) -1.96 %
Johnson & Johnson
JNJ 161.3 (15.10.2021) 0.74 %
Medtronic plc.
MDT 127.75 (15.10.2021) 2.36 %
Merck & Co., Inc.
MRK 78.33 (15.10.2021) 0.00 %
Moderna, Inc.
MRNA 324.21 (15.10.2021) -2.31 %
Novartis AG
NVS 83.33 (15.10.2021) 0.88 %
Novavax, Inc.
NVAX 161.95 (15.10.2021) -4.59 %
ObsEva SA
OBSV 2.74 (15.10.2021) -0.36 %
OrganiGram Holdings Inc.
OGI 2.24 (15.10.2021) -2.61 %
Pfizer Inc.
PFE 41.49 (15.10.2021) -0.43 %
Regeneron Pharmaceuticals, Inc.
REGN 553.24 (15.10.2021) -0.43 %
Sanofi
SNY 48.85 (15.10.2021) 0.54 %
Schrodinger, Inc.
SDGR 55.36 (15.10.2021) 0.64 %
Senseonics Holdings, Inc.
SENS 3.3 (15.10.2021) -3.79 %
Sorrento Therapeutics, Inc.
SRNE 6.84 (15.10.2021) -0.58 %
Stryker Corp.
SYK 266.32 (15.10.2021) 0.94 %
Sundial Growers Inc.
SNDL 0.6561 (15.10.2021) -1.22 %
Teva Pharmaceutical Industries Lim. (TEVA)
TEVA 9.68 (15.10.2021) -0.21 %
Thermo Fisher Scientific Inc.
TMO 582.39 (15.10.2021) 0.87 %
Tilray, Inc.
TLRY 10.24 (15.10.2021) -1.44 %
UnitedHealth Group, Inc.
UNH 428.07 (15.10.2021) 1.83 %
Veeva Systems Inc.
VEEV 309.44 (15.10.2021) 0.37 %
Zomedica Corp.
ZOM 0.5015 (15.10.2021) -2.62 %
Zynerba Pharmaceuticals, Inc.
ZYNE 4.06 (15.10.2021) -1.69 %

Warning: include(include/reklama_bottom.php): failed to open stream: No such file or directory in /home/virtwww/w_leoprophet-com_a7e4ac46/http/wp-content/themes/generatepress/forecast_stock_post_year.php on line 808 Warning: include(): Failed opening 'include/reklama_bottom.php' for inclusion (include_path='.:') in /home/virtwww/w_leoprophet-com_a7e4ac46/http/wp-content/themes/generatepress/forecast_stock_post_year.php on line 808

Denial of responsibility:

The portal leoprophet.com is not responsible for the loss of your money as a result of your use of the information contained on the site, including data, quotes, charts and forecasts. Operations in the stock, foreign exchange and commodity markets involve a high level of risk, and you are solely responsible for your operations. Only speculate with money that you can afford to lose. All prices and forecasts for stocks, indices, futures are indicative and should not be trade dependent. The portal is not responsible for any losses that you may incur as a result of using this data.